omada health inc - OMDA

OMDA

Close Chg Chg %
12.61 -0.03 -0.24%

Closed Market

12.58

-0.03 (0.24%)

Volume: 1.04M

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Company Overview: omada health inc - OMDA

OMDA Key Data

Open

$12.32

Day Range

11.72 - 12.74

52 Week Range

N/A - N/A

Market Cap

$741.28M

Shares Outstanding

58.93M

Public Float

25.50M

Beta

1.33

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.23

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.74M

 

OMDA Performance

1 Week
 
6.12%
 
1 Month
 
-10.46%
 
3 Months
 
-15.57%
 
1 Year
 
N/A
 
5 Years
 
N/A
 

OMDA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About omada health inc - OMDA

Omada Health, Inc. engages in the provision of digital health services. It offers online diabetes and obesity prevention programs, health coaching, and integration of web, mobile, and smart devices. The company was founded by Andrew DiMichele, Adrian James, and Sean Duffy in 2011 and is headquartered in South San Francisco, CA.

OMDA At a Glance

Omada Health, Inc.
611 Gateway Boulevard
South San Francisco, California 94080
Phone 1-888-987-8337 Revenue 260.21M
Industry Internet Software/Services Net Income -12,778,000.00
Sector Technology Services 2025 Sales Growth 53.245%
Fiscal Year-end 12 / 2026 Employees 916
View SEC Filings

OMDA Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 3.543
Price to Book Ratio 4.014
Price to Cash Flow Ratio 50.52
Enterprise Value to EBITDA -108.004
Enterprise Value to Sales 2.69
Total Debt to Enterprise Value N/A

OMDA Efficiency

Revenue/Employee 284,072.052
Income Per Employee -13,949.782
Receivables Turnover 7.388
Total Asset Turnover 1.141

OMDA Liquidity

Current Ratio 3.557
Quick Ratio 3.498
Cash Ratio 2.932

OMDA Profitability

Gross Margin 65.523
Operating Margin -4.601
Pretax Margin -4.911
Net Margin -4.911
Return on Assets -5.601
Return on Equity -8.683
Return on Total Capital -5.563
Return on Invested Capital -7.886

OMDA Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital N/A
Total Debt to Total Assets N/A
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital N/A
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Omada Health Inc - OMDA

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
89.19M 122.78M 169.80M 260.21M
Sales Growth
- +37.67% +38.29% +53.24%
Cost of Goods Sold (COGS) incl D&A
47.16M 53.49M 67.56M 89.71M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
4.33M 4.45M 4.80M 5.49M
Depreciation
2.21M 2.40M 2.80M 3.64M
Amortization of Intangibles
2.12M 2.04M 2.01M 1.85M
COGS Growth
- +13.44% +26.30% +32.78%
Gross Income
42.03M 69.29M 102.23M 170.50M
Gross Income Growth
- +64.86% +47.55% +66.77%
Gross Profit Margin
+47.13% +56.43% +60.21% +65.52%
2022 2023 2024 2025 5-year trend
SG&A Expense
114.38M 135.29M 145.89M 182.47M
Research & Development
26.09M 33.66M 35.84M 40.59M
Other SG&A
88.29M 101.63M 110.05M 141.88M
SGA Growth
- +18.28% +7.84% +25.07%
Other Operating Expense
- - - -
-
Unusual Expense
(1.83M) 2.58M (218.00K) 3.58M
EBIT after Unusual Expense
(70.52M) (68.58M) (43.44M) (15.55M)
Non Operating Income/Expense
2.20M 5.78M 805.00K 5.30M
Non-Operating Interest Income
2.20M 5.78M 805.00K 5.30M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
4.20M 4.71M 4.51M 2.53M
Interest Expense Growth
- +12.00% -4.23% -43.76%
Gross Interest Expense
4.20M 4.71M 4.51M 2.53M
Interest Capitalized
- - - -
-
Pretax Income
(72.52M) (67.51M) (47.14M) (12.78M)
Pretax Income Growth
- +6.90% +30.18% +72.89%
Pretax Margin
-81.31% -54.98% -27.76% -4.91%
Income Tax
- - - -
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(72.52M) (67.51M) (47.14M) (12.78M)
Minority Interest Expense
- - - -
-
Net Income
(72.52M) (67.51M) (47.14M) (12.78M)
Net Income Growth
- +6.90% +30.18% +72.89%
Net Margin Growth
-81.31% -54.98% -27.76% -4.91%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(72.52M) (67.51M) (47.14M) (12.78M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(72.52M) (67.51M) (47.14M) (12.78M)
EPS (Basic)
-1.3009 -1.2111 -0.8456 -0.2187
EPS (Basic) Growth
- +6.90% +30.18% +74.14%
Basic Shares Outstanding
55.74M 55.74M 55.74M 58.43M
EPS (Diluted)
-1.3009 -1.2111 -0.8456 -0.2187
EPS (Diluted) Growth
- +6.90% +30.18% +74.14%
Diluted Shares Outstanding
55.74M 55.74M 55.74M 58.43M
EBITDA
(68.02M) (61.55M) (38.85M) (6.48M)
EBITDA Growth
- +9.51% +36.88% +83.32%
EBITDA Margin
-76.27% -50.13% -22.88% -2.49%

Snapshot

Average Recommendation BUY Average Target Price 22.455
Number of Ratings 11 Current Quarters Estimate -0.026
FY Report Date 06 / 2026 Current Year's Estimate -0.103
Last Quarter’s Earnings -0.13 Median PE on CY Estimate N/A
Year Ago Earnings -0.35 Next Fiscal Year Estimate -0.023
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 5 4 3
Mean Estimate -0.03 0.02 -0.10 -0.02
High Estimates 0.02 0.08 -0.03 0.05
Low Estimate -0.07 -0.02 -0.19 -0.07
Coefficient of Variance -145.44 236.34 -77.79 -275.54

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 8
OVERWEIGHT 1 1 1
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Omada Health Inc - OMDA

Date Name Shares Transaction Value
Mar 12, 2026 Sean Duffy Chief Executive Officer; Director 117,798 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $14.32 per share 1,686,867.36
Mar 12, 2026 Sean Duffy Chief Executive Officer; Director 117,598 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $14.88 per share 1,749,858.24

Omada Health Inc in the News